November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Elvina Almuradova: Using ICis as a first-line treatment may pose a risk of toxicity in unresectable ESCC
Sep 29, 2024, 16:20

Elvina Almuradova: Using ICis as a first-line treatment may pose a risk of toxicity in unresectable ESCC

Elvina Almuradova, Associate Professor of Oncology at Medicana Sağlık Grubu, shared a post on LinkedIn:

“The FDA has expressed concern that in patients with metastatic or unresectable esophageal squamous cell carcinoma, using immune checkpoint inhibitors as a first-line treatment may pose a risk of toxicity without offering a clear benefit for those with low PD-L1 expression (PD-L1 <1).”

Elvina Almuradova: Using ICis as a first-line treatment may pose a risk of toxicity in unresectable ESCC

Read further.
Source: Elvina Almuradova/LinkedIn